SAN DIEGO, Sept. 11, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (Evofem) (OTCID: EVFM) today announced the conclusion and exciting impact of its groundbreaking August 2025 "Say Vagina" campaign, ...
Evofem Biosciences, the buzzy but controversial women’s health startup that spent the past year trying to stay afloat, has finally found a buyer. The San Diego company, which makes the contraceptive ...
Evofem Biosciences targets the women’s health market with specialty products addressing sexual and reproductive conditions. It developed PHEXXI, a hormone-free prescription contraceptive vaginal gel, ...
Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference
SAN DIEGO, Aug. 5, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) is proud to announce that its CEO, Saundra Pelletier, will be honored with the Trailblazing Female Founders Award at the ...
Evofem's meager liquidity presents challenges to its future success. Evofem's shares have been fighting a losing battle to maintain their price above $1.00. Roe v. Wade rescues Evofem and propels it ...
(RTTNews) - Aditxt, Inc. (ADTX) and Evofem Biosciences, Inc. (EVFM), on Tuesday announced a deal allowing Aditxt to buy Evofem for around $100 million, by issuing a combination of common and preferred ...
SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- On World Contraception Day, Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCID: EVFM) honors the millions of people worldwide who rely on ...
Evofem Biosciences (NASDAQ:EVFM) stock soared ~31% post market on Aug. 4 after Q2 net loss narrowed and the women health company reaffirmed its FY22 product sales outlook. Q2 net sales of birth ...
The global hormonal contraceptives market is projected to grow from about $19.5 billion in 2017 to over $30 billion by 2026, according to a study by Transparency Market Research. If one considers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback